Tag: heart failure

CardiAMP Heart Failure Trial continues with first patient randomised in Covid-19...

BioCardia has announced that it has resumed cases in the CardiAMP Heart Failure Trial. The first patient procedure completed since elective procedures were paused...

Smartphone app uses can identify lung congestion in heart failure patients

Voice analysis by a smartphone app can identify lung congestion in heart failure patients, allowing early intervention before their condition deteriorates, a study presented...

ESC to stream the latest science in heart failure

The European Society of Cardiology (ESC) has announced that the HFA Discoveries online event will be running six days of live sessions from 5...

Limited health literacy associated with a higher risk of death in...

According to research published in JACC: Heart Failure, patients with heart failure who experience low health literacy are at an increased risk of hospitalisation...

FDA Breakthrough Device Designation for novel heart failure therapy

VisCardia has been granted Breakthrough Device Designation from the US Food and Drug Administration (FDA) for its implantable VisONE system, which is designed for...

Soft robotic heart could be answer to donor heart shortage

A soft robotic heart that is designed to replace the need for a heart transplant is one of four research projects that have made...

First patients enrolled in PROACTIVE-HF trial of Cordella pulmonary artery pressure...

Endotronix has announced the enrollment of the first two patients in the PROACTIVE-HF trial. The trial is a premarket investigational device exempt (IDE) study...

Heart Research UK awards grant to University of Leeds to develop...

A research project at the University of Leeds aiming to identify new drug treatments for heart failure patients has been awarded a grant of...

FDA approves new device to improve symptoms in patients with advanced...

The US Food and Drug Administration has approved the Barostim Neo system for the improvement of symptoms in patients with advanced heart failure who...

Novel wireless pressure monitoring system will have an “enormous impact” on...

Horst Sievert (Frankfurt, Germany) talks to BLearning at EuroPCR 2019 (21–24 May, Paris, France) about the VECTOR-HF trial which evaluated the safety, usability and performance of a novel wireless pressure...

New Australian research and development partnership aims to innovate heart failure...

Biotronik, the University of Newcastle (in Australia), and the John Hunter New England Local Health District have partnered to shape a future heart failure...

First trial of in-heart micro device for left atrial pressure monitoring...

Vectorious Medical Technologies has announced the initiation of the VECTOR-HF first-in-human (FIH) clinical trial, and the successful first “in-human” implantation of the V-LAPTM monitoring...

EACTS 2018: From bench to bedside: Roundtrip for cell therapy in...

The study of stem cells in regenerative medicine is a growing field of basic and clinical research, generating a broad interest and debate in...

HeartWare HVAD system receives US FDA approval

Medtronic has received United States Food and Drug Administration (FDA) approval for a less-invasive implant approach of its HVAD System, a left ventricular assist...

Nearly 25% of chronic ischaemic heart disease patients dead or hospitalised...

    Nearly a quarter of patients with chronic ischaemic cardiovascular disease are dead or hospitalised within six months, reports a European Society of Cardiology (ESC) study...

Abbott’s Full MagLev HeartMate 3 LVAD receives FDA approval

The FDA has approved the Full MagLev HeartMate 3 (Abbott) left ventricular assist device for use in heart failure patients in need of short-term...
Woman patient

Heart failure patient and clinician risk perceptions differ drastically

Physicians identified a majority of patients with advanced heart failure as at high risk for transplant, left ventricular assist device (LVAD) or death while...

EuroPCR 2017: Interventional management of acute heart failure—which device, when and...

In this PCR video, filmed during EuroPCR (16–19 May, Paris, France), Atul Pathak (Clinique Pasteur, Toulouse, France) speaks to Daniel Burkhoff (Division of Cardiology, Columbia...

Halting methamphetamine abuse can reverse related heart damage

Quitting methamphetamine use can reverse the damage the drug causes to the heart and improve heart function in abusers when combined with appropriate medical...

Non-O blood groups associated with higher risk of heart attack

Having a non-O blood group is associated with a higher risk of heart attack, according to research presented at Heart Failure 2017 and the...

ACC 2017: More hospitalisations & deaths for US heart failure patients...

Patients with heart failure in the USA are more likely to be hospitalised and more likely to die during the colder winter months, according...

First patient treated with CardiAmp cell therapy for ischaemic heart failure...

Johns Hopkins Medicine, Baltimore, USA, the Maryland Stem Cell Research Fund (MSCRF) and BioCardia have announced that the first patient has been treated in...

Increased physical activity, lower BMI may lower heart failure risk

While lifestyle patterns, including physical activity and body mass index (BMI), are associated with overall heart failure risk, they are more strongly associated with...

Cancer drug promotes regeneration of damaged heart tissue

An anticancer agent in development has been shown to promote regeneration of damaged heart muscle—an unexpected research finding that may help prevent congestive heart...

Northwestern Memorial Hospital ranked best in USA for heart attack, stroke...

Northwestern Memorial Hospital has been ranked best in the USA for survival of patients suffering heart failure, and second for survival of patients with...

Latest statistics show heart failure on the rise

The number of adults living with heart failure increased from about 5.7 million (2009-2012) to about 6.5 million (2011-2014), according to the American Heart...

AHA 2016: Elizabeth M McNally wins AHA prize for research into...

The American Heart Association (AHA) awarded its Basic Research Prize for 2016 to Elizabeth M McNally (Chicago, USA) for “Ground-breaking investigations of novel genetic...

Japan approves Abiomed’s Impella 2.5 and Impella 5.0 heart pumps

Abiomed has announced that its heart pumps Impella 2.5 and Impella 5.0 have received Pharmaceuticals and Medical Devices Agency (PMDA) approval from the Japanese...

Berlin Heals announces closure of second round funding for cardiac microcurrent...

Berlin Heals has closed a second investment round in the run-up to the first-in-man application of its implantable medical device for the treatment of...